 But, this effort was hampered by a string of adverse regulatory findings.From 2002 to 2005, García's company, without admitting or denying any allegations, accepted six fines totaling $456,000 for NASD rule violations.Reported problems included issuing research reports that contained errors and exaggerations, lax record keeping, and weak monitoring of branch offices.